Skip to main
ADNT
ADNT logo

Adient (ADNT) Stock Forecast & Price Target

Adient (ADNT) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 13%
Buy 13%
Hold 50%
Sell 25%
Strong Sell 0%

Bulls say

Adient, a prominent seating supplier in the automotive industry with approximately a midteens market share globally, reported consolidated revenue of $14.5 billion for fiscal 2025, excluding joint venture sales. As management anticipates gaining additional market share through onshored production and targeted reshoring programs, there is potential for substantial revenue growth as these initiatives could significantly increase overall volume. Furthermore, management expects margin expansion of 5.0%-5.5% over the next 2-3 years, indicating a strong commitment to improving profitability and enhancing financial performance.

Bears say

Adient's stock outlook is negatively influenced by persistent challenges stemming from loss-making metals contracts and uncompetitive plants, which have hindered profitability and cash flow since the company's spin-off from Johnson Controls in 2016. Additionally, reduced vehicle production and an unfavorable production mix in the EMEA region have further pressured Adient's revenue, contributing to a decline in financial performance. Furthermore, ongoing geopolitical and macroeconomic factors are expected to exacerbate these issues, particularly impacting European production in the near future.

Adient (ADNT) has been analyzed by 8 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 13% recommend Buy, 50% suggest Holding, 25% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Adient and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Adient (ADNT) Forecast

Analysts have given Adient (ADNT) a Hold based on their latest research and market trends.

According to 8 analysts, Adient (ADNT) has a Hold consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Adient (ADNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.